Updates
June 4, 2024
Court Grants Final Approval to $46.5 Million Class Action Settlement
This month The Block Firm obtained final approval of a $46.5 million class action settlement, which will benefit over a million class members nationwide. The…
May 30, 2024
The Block Firm Files Class Action About Contaminated Drugs
This week The Block Firm, partnering with our good friends at Anderson & Shah, filed a class action (read complaint here) against the manufacturer of…
May 21, 2024
Attorney Max Marks Argues on behalf of Fitzgerald Fruit Farms in front of the Supreme Court of Georgia in Case Whitaker Farms LLC vs. Fitzgerald Farms LLC
On May 16, 2024 Max Marks argued on behalf of Fitzgerald Farms in front of the Supreme Court of Georgia, defending his victories at trial and before…
May 17, 2024
FDA Recalls Duloxetine: The Block Firm continues to investigate
The U.S. Food and Drug Administration (FDA) has recently issued a recall for duloxetine, a medication commonly prescribed for depression and anxiety. If you or…
May 8, 2024
The Block Firm Investigates the Presence of Carcinogens in Duloxetine (Generic Cymbalta)
Millions of Americans take the drug duloxetine—a generic form of Cymbalta—for depression, pain, and anxiety. According to a recent FDA announcement, tens of millions of…
March 20, 2024
The Block Firm Investigates Unapproved Thyroid Drug, Adthyza
The Block Firm is investigating a new potential case regarding Adthyza, an unapproved thyroid drug manufactured by Azurity. At The Block Firm, we believe that…
March 15, 2024
Unapproved Prescription Drugs Are Rampant—and Can Harm Your Health.
Many Americans trust that prescription drugs have been approved by the Food & Drug Administration and are safe and effective for patients to take. After…
February 20, 2024
Neptune’s Fix Elixir Recalled by the FDA Due to Potentially Harmful Ingredient, Tianeptine
The Block Firm is investigating a potential class action lawsuit against Neptune’s Resources, LLC, the manufacturer of Neptune’s Fix Elixir, Neptune’s Fix Extra Strength Elixir,…
February 16, 2024
The Block Firm Receives Preliminary Approval of $46.5 Million Class Action Settlement
Since 2022, The Block Firm has been pursuing a class action against Acella Pharmaceuticals, the manufacturer of NP Thyroid. The class action alleges that Acella…
January 10, 2024
The Block Firm Investigates a Potential Class Action Against MiMedx Group, Inc.
The Block Firm is investigating a potential class action lawsuit against MiMedx Group, Inc., the maker of the AXIOFILL wound treatment. According to a recently…
OUR PEOPLE
We’re here when you need us.
